Related references
Note: Only part of the references are listed.Amikacin-Fosfomycin at a Five-to-Two Ratio: Characterization of Mutation Rates in Microbial Strains Causing Ventilator-Associated Pneumonia and Interactions with Commonly Used Antibiotics
A. Bruce Montgomery et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow® Inline Nebulizer System in Mechanically Ventilated Patients
A. Bruce Montgomery et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow((R)) Inline Nebulizer System in Mechanically Ventilated Patients
Paul Robinson
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa
David L. MacLeod et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Is the Gram Stain Useful in the Microbiologic Diagnosis of VAP? A Meta-analysis
John C. O'Horo et al.
CLINICAL INFECTIOUS DISEASES (2012)
BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia
Michael S. Niederman et al.
INTENSIVE CARE MEDICINE (2012)
Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused by Pseudomonas aeruginosa
Qin Lu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
David L. MacLeod et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit
Lucy B. Palmer et al.
CRITICAL CARE MEDICINE (2008)
Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Utility of gram stain in the clinical management of suspected ventilator-associated pneumonia: Secondary analysis of a multicenter randomized trial
M. Albert et al.
JOURNAL OF CRITICAL CARE (2008)
Predictive Value of Broncho-Alveolar Lavage Fluid Gram's Stain in the Diagnosis of Ventilator-Associated Pneumonia: A Prospective Study
Aaron E. Goldberg et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection
George Z. Retsch-Bogart et al.
PEDIATRIC PULMONOLOGY (2008)
Ventilator-associated pneumonia: Diagnosis, treatment, and prevention
Steven M. Koenig et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles
R Sauermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Impact of clinical guidelines in the management of severe hospital-acquired pneumonia
GWS Hoo et al.
CHEST (2005)
Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients
GC Wood et al.
PHARMACOTHERAPY (2002)
Share Paper
